Comparing Newly Developed PreCore Needle With Conventional Fine Needle in Endoscopic Ultrasonography-guided Sampling of Suspected Unresectable Pancreatic Cancer
Newly diagnosed pancreatic cancer patient whose cancer lesion is suspected unresectable in
diagnostic imaging such as CT or MRI
Each EUS-guided FNA and ProCore aspiration will performed twice in same patient. The
priority of order will be given by randomization assignment.
The number of patients required:
Total sixty five patients will be required.
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
The rates of diagnostic sufficiency
The rates of diagnostic sufficency will be assessed by the pathologist as the proportion of definate diagnosis from cytology and histology within 2 passes of each procendure
Up to 1 year
Kwang Hyuck Lee, MD.
Samsung Medical Center
Korea: Institutional Review Board